Mini-Review
Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

https://doi.org/10.1016/j.ajpath.2013.01.010Get rights and content
Under a Creative Commons license
open access

Over the past three decades, age-adjusted rates of cardiovascular morbidity and mortality have fallen in the United States, but the prevalence of obesity and associated metabolic disorders has risen dramatically. Recent studies have begun to unravel the complex linkages between adipose and vascular tissues that may accelerate the development of atherosclerosis in the context of obesity. Experimental models indicate that inflammation and oxidative stress, which mutually amplify each other within the vasculature and in visceral fat, are key processes that drive the initiation, progression, and subsequent rupture of the atherosclerotic lesion. Emerging research is further elucidating the contributions made by chemokines and their receptors, adipokines, and miRNAs to arterial disease. Translation of these basic science findings to clinical applications represents a tantalizing possibility for reducing the global burden of obesity-associated atherosclerosis and other cardiovascular diseases.

Cited by (0)

Supported by the NIH grants P01 HL-46403 and R01 HL-091101 and the Julia & Seymour Gross Foundation (D.P.H.).

Disclosures: D.P.H. is a consultant to KOWA Pharmaceutical Corp., Japan. A.M.G. is a consultant for AstraZeneca, Janssen, KOWA, Merck, and Roche; a member of the Board of Directors for Aegerion Pharmaceuticals and Arisaph Pharmaceuticals; and a member of advisory boards for DuPont, Haptocure, VascuVis, and Vatera Capital.